Andrew Kuo

1.2k total citations
22 papers, 669 citations indexed

About

Andrew Kuo is a scholar working on Molecular Biology, Cell Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Andrew Kuo has authored 22 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Cell Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Andrew Kuo's work include Sphingolipid Metabolism and Signaling (10 papers), Lipid metabolism and disorders (4 papers) and Caveolin-1 and cellular processes (4 papers). Andrew Kuo is often cited by papers focused on Sphingolipid Metabolism and Signaling (10 papers), Lipid metabolism and disorders (4 papers) and Caveolin-1 and cellular processes (4 papers). Andrew Kuo collaborates with scholars based in United States, Japan and Sweden. Andrew Kuo's co-authors include William C. Sessa, Monica Y. Lee, Timothy Hla, Eon Joo Park, Kenneth Harrison, Kui Yang, Richard W. Gross, Ningguo Gao, Jeffrey S. Rush and Charles J. Waechter and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Andrew Kuo

21 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Kuo United States 14 411 150 95 89 86 22 669
Tomoyuki Nakano Japan 18 591 1.4× 153 1.0× 107 1.1× 133 1.5× 107 1.2× 54 843
Christine Bénistant France 17 560 1.4× 164 1.1× 89 0.9× 84 0.9× 74 0.9× 35 893
Young‐Hwa Goo United States 14 467 1.1× 48 0.3× 54 0.6× 128 1.4× 72 0.8× 19 690
Kristina M. Fetalvero United States 10 288 0.7× 53 0.4× 89 0.9× 80 0.9× 40 0.5× 12 575
Huasong Tian United States 9 353 0.9× 137 0.9× 132 1.4× 34 0.4× 87 1.0× 13 609
Sonal S. Sheth United States 9 520 1.3× 160 1.1× 130 1.4× 60 0.7× 78 0.9× 10 683
Reigh-Yi Lin United States 12 469 1.1× 60 0.4× 119 1.3× 46 0.5× 62 0.7× 18 984
Non Miyata Japan 17 807 2.0× 124 0.8× 213 2.2× 94 1.1× 49 0.6× 25 1.0k
Michael C. Kacergis United States 8 616 1.5× 235 1.6× 106 1.1× 38 0.4× 103 1.2× 8 891
Tatsuya Kishimoto Japan 10 659 1.6× 228 1.5× 167 1.8× 123 1.4× 37 0.4× 15 836

Countries citing papers authored by Andrew Kuo

Since Specialization
Citations

This map shows the geographic impact of Andrew Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Kuo more than expected).

Fields of papers citing papers by Andrew Kuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Kuo. The network helps show where Andrew Kuo may publish in the future.

Co-authorship network of co-authors of Andrew Kuo

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Kuo. A scholar is included among the top collaborators of Andrew Kuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Kuo. Andrew Kuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chai, Peiyuan, Sina Kheiri, Andrew Kuo, et al.. (2026). GlycoRNA complexed with heparan sulfate regulates VEGF-A signalling. Nature. 651(8106). 808–818.
2.
Jung, B., Andrew Kuo, Masanori Aikawa, et al.. (2025). ApoM-bound S1P acts via endothelial S1PR1 to suppress choroidal neovascularization and vascular leakage. Angiogenesis. 28(2). 24–24. 2 indexed citations
3.
Burg, Nathalie, Linda Alex, Andrew Kuo, et al.. (2024). Endothelial cell sphingosine 1-phosphate receptor 1 restrains VE-cadherin cleavage and attenuates experimental inflammatory arthritis. JCI Insight. 9(11). 3 indexed citations
4.
Kuo, Andrew & Timothy Hla. (2024). Regulation of cellular and systemic sphingolipid homeostasis. Nature Reviews Molecular Cell Biology. 25(10). 802–821. 35 indexed citations
5.
Boutagy, Nabil E., Ana María Gámez-Méndez, Joseph W. Fowler, et al.. (2024). Dynamic metabolism of endothelial triglycerides protects against atherosclerosis in mice. Journal of Clinical Investigation. 134(4). 23 indexed citations
6.
Niaudet, Colin, B. Jung, Andrew Kuo, et al.. (2023). Therapeutic activation of endothelial sphingosine‐1‐phosphate receptor 1 by chaperone‐bound S1P suppresses proliferative retinal neovascularization. EMBO Molecular Medicine. 15(5). e16645–e16645. 13 indexed citations
7.
Brazee, Patricia L., Andréane Cartier, Andrew Kuo, et al.. (2023). Augmentation of Endothelial S1PR1 Attenuates Postviral Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 70(2). 119–128. 4 indexed citations
8.
Kuo, Andrew, Antonio Checa, Colin Niaudet, et al.. (2022). Murine endothelial serine palmitoyltransferase 1 (SPTLC1) is required for vascular development and systemic sphingolipid homeostasis. eLife. 11. 14 indexed citations
9.
Yanagida, K., Eric Engelbrecht, Colin Niaudet, et al.. (2020). Sphingosine 1-Phosphate Receptor Signaling Establishes AP-1 Gradients to Allow for Retinal Endothelial Cell Specialization. Developmental Cell. 52(6). 779–793.e7. 40 indexed citations
10.
Engelbrecht, Eric, Liqun He, Michael Vanlandewijck, et al.. (2020). Sphingosine 1-phosphate-regulated transcriptomes in heterogenous arterial and lymphatic endothelium of the aorta. eLife. 9. 34 indexed citations
11.
Pandey, Suveg, Ritu Kumar, Andrew Kuo, et al.. (2020). Sphingosine kinases protect murine embryonic stem cells from sphingosine-induced cell cycle arrest. Stem Cells. 38(5). 613–623. 3 indexed citations
12.
Obinata, Hideru, Andrew Kuo, Steven Swendeman, et al.. (2019). Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient mice. Journal of Lipid Research. 60(11). 1912–1921. 38 indexed citations
13.
Hisano, Yu, Mari Kono, Andréane Cartier, et al.. (2019). Lysolipid receptor cross-talk regulates lymphatic endothelial junctions in lymph nodes. The Journal of Experimental Medicine. 216(7). 1582–1598. 49 indexed citations
14.
Kuo, Andrew, Monica Y. Lee, Kui Yang, Richard W. Gross, & William C. Sessa. (2017). Caveolin-1 regulates lipid droplet metabolism in endothelial cells via autocrine prostacyclin–stimulated, cAMP-mediated lipolysis. Journal of Biological Chemistry. 293(3). 973–983. 64 indexed citations
15.
Kuo, Andrew, Monica Y. Lee, & William C. Sessa. (2017). Lipid Droplet Biogenesis and Function in the Endothelium. Circulation Research. 120(8). 1289–1297. 113 indexed citations
16.
József, Levente, K Tashiro, Andrew Kuo, et al.. (2014). Reticulon 4 Is Necessary for Endoplasmic Reticulum Tubulation, STIM1-Orai1 Coupling, and Store-operated Calcium Entry. Journal of Biological Chemistry. 289(13). 9380–9395. 62 indexed citations
17.
Gandhi, Sumeet, et al.. (2013). The management of Brugada syndrome unmasked by fever in a patient with cellulitis. BMJ Case Reports. 2013. bcr2013009063–bcr2013009063. 3 indexed citations
18.
Li, Qi, Michael Michaud, Sandra Canosa, Andrew Kuo, & Joseph A. Madri. (2011). GSK-3β: a signaling pathway node modulating neural stem cell and endothelial cell interactions. Angiogenesis. 14(2). 173–185. 27 indexed citations
19.
Harrison, Kenneth, Eon Joo Park, Ningguo Gao, et al.. (2011). Nogo‐B receptor is necessary for cellular dolichol biosynthesis and protein N‐glycosylation. The EMBO Journal. 30(12). 2490–2500. 92 indexed citations
20.
Lasley, Bill L., Andrew Kuo, Ellen B. Gold, et al.. (1995). Laboratory methods for evaluating early pregnancy loss in an industry‐based population. American Journal of Industrial Medicine. 28(6). 771–781. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomoyuki Nakano Breakdown of academic impact, for papers by Christine Bénistant Breakdown of academic impact, for papers by Young‐Hwa Goo Breakdown of academic impact, for papers by Kristina M. Fetalvero Breakdown of academic impact, for papers by Huasong Tian Breakdown of academic impact, for papers by Sonal S. Sheth Breakdown of academic impact, for papers by Reigh-Yi Lin Breakdown of academic impact, for papers by Non Miyata Breakdown of academic impact, for papers by Michael C. Kacergis Breakdown of academic impact, for papers by Tatsuya Kishimoto
Rankless by CCL
2026